Advisory Role

Providing expertise and consultation on request for companies and researchers developing treatments for HD.

HD Clinical R&D Advisory

We are happy to support partners across all stages of the drug development cycle to optimize:
• Clinical development strategy
• Protocol design and development
• Mechanism of treatment action and outcome measures
• Statistical matters
• Operational matters

If you are working on a therapy for HD and have a question or would like to request the support of the HD-CTTF please contact Tim McLean at for further details.


HD trials

HD trials